4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017398
Chief Business Development Off sold 2,670 shares at $12.01 ($32,067)
- Chief Business Development Off acquired 82,372 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2022-03-04 | Grant or award | +82,372 | 105,266 | D: show line 1 in the form | ||
| BENZENO SHARON Chief Business Development Off | 2022-03-07 | Sale | −2,670 | $12.01 | $32,067 | 102,596 | D: show line 2 in the form |
| Open-market sales · 2,670 sh · avg $12.01 · $32,067 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2022-03-04 | Grant or award · Stock Option (Right to Buy) | +205,931 | 205,931 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…